Amy Shapiro
Chief Executive Officer · Medical College of Wisconsin Affiliated Hospitals, Inc
Credentials: · ·
History
Pediatrics
Research
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
New England Journal of Medicine · 2007 · 1,576 citations
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
Blood · 2014 · 386 citations
Blood · 1994 · 330 citations
- MR
25 papers
- SG
20 papers
- JL
18 papers
18 papers
- CN
17 papers
- RK
16 papers
- BE
14 papers
- DD
14 papers
Grants
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $69.9K · Indiana University Indianapolis
Clinical trials
- 2022–2027
Principal investigator · Recruiting · Phase 4
Indiana Hemophilia &Thrombosis Center, Inc.
- 2019–2022
HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
Principal investigator · Terminated · Phase 4
Indiana Hemophilia &Thrombosis Center, Inc.
- 2018–2029
Study of Individuals Affected With Hypoplasminogenemia
Principal investigator · Recruiting
Indiana Hemophilia &Thrombosis Center, Inc.
- 2016–2018
A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia
Principal investigator · Completed · Phase 2, Phase 3
Prometic Biotherapeutics, Inc.